Related Experiment Video
Updated: Aug 23, 2026
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Current applications for nicardipine in invasive and interventional cardiology
Tim A Fischell1, Alok Maheshwari
1Borgess Heart Institute, Professor of Medicine, Michigan State University, 1521 Gull Road, Kalamazoo, MI 49048-1666, USA. taf1@net-link.net
Insights
Nicardipine injection, a calcium channel blocker, effectively prevents and reverses vasoconstriction during interventional cardiology procedures. It offers a safer, predictable option for managing complications like no-reflow and hypertension.
Area of Science:
- Cardiology
- Pharmacology
- Interventional Cardiovascular Medicine
Background:
- Interventional coronary procedures carry a risk of postoperative vasoconstriction, potentially leading to severe morbidity or death.
- Vasodilators like calcium channel blockers are crucial for preventing and treating these adverse effects.
- Nicardipine, an injectable dihydropyridine calcium channel blocker, presents unique properties beneficial in cardiovascular interventions.
Purpose of the Study:
- To review the evidence-based applications of nicardipine injection in interventional cardiology and cardiac catheterization.
- To highlight nicardipine's advantages over other calcium channel blockers in managing procedural complications.
Main Methods:
- Review of existing literature and clinical evidence on nicardipine's use in cardiovascular interventions.
- Comparative analysis of nicardipine's efficacy, safety, and administration profile against other vasodilators.
Main Results:
- Nicardipine injection demonstrates effectiveness in preventing and reversing microvascular and conductance vessel vasoconstriction.
- It shows potential advantages in managing the no-reflow phenomenon post-coronary bypass graft interventions.
- Nicardipine is also effective in controlling post-sternotomy hypertension and in cardiac catheterization settings.
Conclusions:
- Nicardipine injection is a versatile and effective agent for managing vasoconstriction and hypertension during various cardiovascular interventions.
- Its safety profile, ease of administration, and predictable response make it a valuable therapeutic option in interventional cardiology.
Abstract:
Interventional coronary procedures, such as rotational atherectomy and coronary artery bypass graft (CABG) stenting, are associated with a risk of postoperative vasoconstriction, which can lead to sequelae that produce morbidity and even death. Vasodilators, such as calcium channel blockers, sodium nitroprusside and adenosine, are often administered to prevent or reverse these sequelae, and have proven effective for this purpose. The injectable dihydropyridine calcium channel blocker, nicardipine, has several unique properties that make it an effective option for preventing and/or reversing microvascular or conductance vessel vasoconstriction. In this review, we describe the evidence-based uses of nicardipine injection in interventional cardiology and cardiac catheterization procedures. In comparison to other calcium channel blockers, nicardipine injection appears to be potentially safer, easier to administer and capable of producing a more predictable response. This drug has potential advantages in preventing or reversing the no-reflow phenomenon that sometimes occurs after interventions in coronary bypass grafts. Nicardipine may also be effective when administered in a flush solution with other drugs during rotational atherectomy and clot debulking with or without distal protection devices. It also can control the hypertension that occurs after sternotomy and cardiac surgery, and in the cardiac catheterization laboratory. In summary, the dihydropyridine calcium channel blocker, nicardipine, has a wide range of useful applications during cardiovascular interventions.
Related Concept Videos
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:27Coronary Artery Disease V: Interprofessional Care
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Cardiac Catheterization IV: Nursing Management
01:28Cardiac Catheterization I: Pre-Procedure Overview
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...